ArticleCancers2025
Radiomics Features from Different Prostatic Zones on
Licong Li, Jian Xu, Shuying Bian, Fei Yao, Qi Lin, Meiyan Zhou, Yunjun Yang, Meiyao Song, Yixuan Pan, Qinyang Shen and 2 more
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Licong LiThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.ORCID 0009-0002-1427-9324 Jian XuThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Shuying BianThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Fei YaoThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Qi LinThe Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Meiyan ZhouThe Department of Radiology, The People's Hospital of Yuhuan, Yuhuan 317600, China.
Yunjun YangThe Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Meiyao SongThe First School of Clinical Medicine (School of Information and Engineering), Wenzhou Medical University, Wenzhou 325000, China.
Yixuan PanThe First School of Clinical Medicine (School of Information and Engineering), Wenzhou Medical University, Wenzhou 325000, China.
Qinyang ShenThe First School of Clinical Medicine (School of Information and Engineering), Wenzhou Medical University, Wenzhou 325000, China.
Yuandi ZhuangThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.ORCID 0000-0002-7365-2531 Jie LinThe Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.ORCID 0009-0000-1139-463X Funding
Discipline Cluster of Oncology of Wenzhou Medical University z1-2023008Project of Wenzhou Science and Technology Bureau Y2023194Project of Yuhuan Science and Technology Bureau 2024086the Key Laboratory of Novel Nuclide Technologies on Precision Diagnosis and Treatment & clin-ical Transformation of Wenzhou 2023HZSY0012the Summit Advancement Disciplines of Zhejiang Province (Wenzhou Medical University - Pharmaceutics) no
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
persistent PSAPET/CTprostate cancerradiomicstumor microenvironment
Identifiers
PMID40940904
PMCPMC12427274
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390